BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Innovasis Announces Successful FDA Clearance For The 'PEEK Box' VBR System


1/8/2007 2:07:20 PM

SALT LAKE CITY, Jan. 5 /PRNewswire/ -- Utah-based Innovasis, a research, development and manufacturer of spinal implant devices, has received 510(k) clearance of its "PEEK Box" System as a Vertebral Body Replacement (VBR) by the United States Food and Drug Administration after previously been cleared as a Cement Restrictor.

The "PEEK Box" System will be used as a Vertebral Body Replacement within the spine. The Innovasis "PEEK Box" System is manufactured from PolyEtherEtherKetone (PEEK) with Tantalum markers. PolyEtherEtherKetone (PEEK) is a material with an elasticity module (GPA) that is the closest to Cancellous Bone compared to Cortical Bone, Titanium or Stainless Steel implants.

Features and benefits of the "PEEK Box" system include: Variety of different shapes, proud angled tooth design on superior and inferior surfaces to resist migration, Bullet-shaped tip to assist in distraction, and parallel and lordotic-shaped with large central windows for placement of bone graft.

"This is good news for our company as we strive to be a recognized leader in the global spinal business by building intense customer loyalty and improving our products," said Martin Crous, Ph.D., Vice President of Sales and Marketing of Innovasis.

Other products already cleared by the FDA for Innovasis include the Le Forte Cranial Plating System, the Excella-M Pedical Screw System and the Opteryx Cervical Plate System.

Innovasis offers spinal product implants and instruments that address major pathologies and focus areas of traditional spinal surgery, including deformities, degenerative conditions; trauma and tumors, all of which can result in severe back pain and sometimes paralysis. Spinal implants are aimed at restoring mechanical and neurological function by readjusting vertebral positioning until bone fusion occurs. Founded in 2002, Innovasis is committed to providing surgeons with training, support and excellent customer service.

For information on Innovasis contact Martin Crous, Ph.D., at 801-261-2242 or mcrous@innovasis.com or visit the website at www.innovasis.com.

Innovasis

CONTACT: Martin Crous, Ph.D., of Innovasis, +1-801-261-2242,mcrous@innovasis.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES